{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:27:26Z","timestamp":1793852846230,"version":"4.6.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jclinepi.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Epidemiology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jclinepi.2026.112443","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T23:33:40Z","timestamp":1786145620000},"page":"112443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development and internal validation of a clinical risk score for lost to follow-up among drug-resistant tuberculosis patients in a high-burden setting, Ethiopia, 2025: a multicenter retrospective follow-up study"],"prefix":"10.1016","volume":"199","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4673-4523","authenticated-orcid":false,"given":"Tilahun Nega","family":"Godana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fantahun Ayenew","family":"Mekonnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1355-2763","authenticated-orcid":false,"given":"Nebiyu Mekonnen","family":"Derseh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jclinepi.2026.112443_bib1","doi-asserted-by":"crossref","first-page":"e0132543","DOI":"10.1371\/journal.pone.0132543","article-title":"Loss-to-follow-up on multidrug resistant tuberculosis treatment in Gujarat, India: the when and who of it","volume":"10","author":"Shringarpure","year":"2015","journal-title":"PloS one"},{"issue":"10","key":"10.1016\/j.jclinepi.2026.112443_bib2","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41579-024-01025-1","article-title":"Drug-resistant tuberculosis: a persistent global health concern","volume":"22","author":"Farhat","year":"2024","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jclinepi.2026.112443_bib3","article-title":"Strengthening the global Response to tuberculosis: insights from the 2024 WHO global TB report","volume":"39","author":"Estaji","year":"2025","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"10.1016\/j.jclinepi.2026.112443_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193903","article-title":"Unacceptable treatment outcomes and associated factors among India\u2019s initial cohorts of multidrug-resistant tuberculosis (MDR-TB) patients under the revised national TB control programme (2007\u20132011): evidence leading to policy enhancement","volume":"13","author":"Parmar","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jclinepi.2026.112443_bib5","doi-asserted-by":"crossref","first-page":"e0287966","DOI":"10.1371\/journal.pone.0287966","article-title":"Unsuccessful treatment outcome and associated risk factors. A prospective study of DR-TB patients from a high burden country, Pakistan","volume":"18","author":"Massud","year":"2023","journal-title":"PLOS ONE"},{"key":"10.1016\/j.jclinepi.2026.112443_bib6","doi-asserted-by":"crossref","first-page":"e0132543","DOI":"10.1371\/journal.pone.0132543","article-title":"Loss-To-Follow-Up on multidrug resistant tuberculosis treatment in Gujarat, India: the WHEN and WHO of it","volume":"10","author":"Shringarpure","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jclinepi.2026.112443_bib7","doi-asserted-by":"crossref","DOI":"10.1186\/s40249-020-00719-x","article-title":"Treatment quality and outcome for multidrug-resistant tuberculosis patients in four regions of China: a cohort study","volume":"9","author":"Zheng","year":"2020","journal-title":"Infect Dis Poverty"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112443_bib8","first-page":"1","article-title":"Tuberculosis treatment non-adherence and lost to follow up among TB patients with or without HIV in developing countries: a systematic review","volume":"44","author":"Tola","year":"2015","journal-title":"Iran J Public Health"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112443_bib9","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s12890-021-01735-9","article-title":"Determinant factors for loss to follow-up in drug-resistant tuberculosis patients: the importance of psycho-social and economic aspects","volume":"21","author":"Soedarsono","year":"2021","journal-title":"BMC Pulm Med"},{"issue":"3","key":"10.1016\/j.jclinepi.2026.112443_bib10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.5588\/pha.24.0004","article-title":"Loss to follow-up among adults with drug-resistant TB in Papua New Guinea","volume":"14","author":"Charles","year":"2024","journal-title":"Public Health Action"},{"issue":"3","key":"10.1016\/j.jclinepi.2026.112443_bib11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.5588\/pha.21.0007","article-title":"Risk factors for poor engagement in drug-resistant TB care in South Africa: a systematic review","volume":"11","author":"McNabb","year":"2021","journal-title":"Public Health Action"},{"key":"10.1016\/j.jclinepi.2026.112443_bib12","doi-asserted-by":"crossref","first-page":"e0261152","DOI":"10.1371\/journal.pone.0261152","article-title":"Reasons for loss to follow-up (LTFU) of pulmonary TB (PTB) patients: a qualitative study among Saharia, a particularly vulnerable tribal group of Madhya Pradesh, India","volume":"16","author":"Mishra","year":"2021","journal-title":"PLOS ONE"},{"issue":"9","key":"10.1016\/j.jclinepi.2026.112443_bib13","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.5588\/ijtld.15.0167","article-title":"Management and treatment outcomes of MDR-TB: results from a setting with high rates of drug resistance","volume":"19","author":"Ahmad","year":"2015","journal-title":"Int J Tuberculosis Lung Dis"},{"issue":"6","key":"10.1016\/j.jclinepi.2026.112443_bib14","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jiph.2019.04.009","article-title":"Evaluation of treatment outcomes and factors associated with unsuccessful outcomes in multidrug resistant tuberculosis patients in Baluchistan province of Pakistan","volume":"12","author":"Khan","year":"2019","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.jclinepi.2026.112443_bib15","series-title":"Evaluation of treatment outcomes and factors associated with unsuccessful outcomes in multidrug resistant tuberculosis patients in Baluchistan province of Pakistan","author":"Khan","year":"2019"},{"key":"10.1016\/j.jclinepi.2026.112443_bib16","doi-asserted-by":"crossref","first-page":"e0248687","DOI":"10.1371\/journal.pone.0248687","article-title":"Lost to follow-up and associated factors among patients with drug resistant tuberculosis in Ethiopia: a systematic review and meta-analysis","volume":"16","author":"Andargie","year":"2021","journal-title":"PLOS ONE"},{"key":"10.1016\/j.jclinepi.2026.112443_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1151077","article-title":"Loss to follow-up tuberculosis treatment and associated factors among adults attending at public health facilities in Warder District, Somali Regional State, Eastern Ethiopia","volume":"11","author":"Birhane","year":"2023","journal-title":"Front Public Health"},{"issue":"4","key":"10.1016\/j.jclinepi.2026.112443_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003343.pub3","article-title":"Directly observed therapy for treating tuberculosis","author":"Volmink","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.jclinepi.2026.112443_bib19","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00135-2023","article-title":"Retreatment after loss to follow-up reduces mortality in patients with multidrug\/rifampicin-resistant tuberculosis","volume":"9","author":"Choi","year":"2023","journal-title":"ERJ Open Res"},{"issue":"8","key":"10.1016\/j.jclinepi.2026.112443_bib20","doi-asserted-by":"crossref","first-page":"811","DOI":"10.5588\/ijtld.19.0754","article-title":"Clinical and economic impact of medication non-adherence in drug-susceptible tuberculosis: a systematic review","volume":"24","author":"Chimeh","year":"2020","journal-title":"Int J Tuberculosis Lung Dis"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112443_bib21","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1186\/s12879-019-4447-8","article-title":"Incidence and predictors of lost to follow-up among drug-resistant tuberculosis patients at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia: a retrospective follow-up study","volume":"19","author":"Kassa","year":"2019","journal-title":"BMC Infect Dis"},{"issue":"7","key":"10.1016\/j.jclinepi.2026.112443_bib22","doi-asserted-by":"crossref","first-page":"955","DOI":"10.5588\/ijtld.11.0502","article-title":"Impact of patient and program factors on default during treatment of multidrug-resistant tuberculosis","volume":"16","author":"Gler","year":"2012","journal-title":"Int J Tuberculosis Lung Dis"},{"key":"10.1016\/j.jclinepi.2026.112443_bib23","doi-asserted-by":"crossref","first-page":"e0250804","DOI":"10.1371\/journal.pone.0250804","article-title":"Predictors of mortality and loss to follow-up among drug resistant tuberculosis patients in Oromia Hospitals, Ethiopia: a retrospective follow-up study","volume":"16","author":"Woldeyohannes","year":"2021","journal-title":"PLOS ONE"},{"issue":"5","key":"10.1016\/j.jclinepi.2026.112443_bib24","first-page":"e00048217","article-title":"Factors associated with loss to follow-up and death in cases of drug-resistant tuberculosis (DR-TB) treated at a reference center in Rio de Janeiro, Brazil","volume":"34","author":"Viana","year":"2018","journal-title":"Cad Saude Publica"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112443_bib25","article-title":"Predictive machine learning models for anticipating loss to follow-up in tuberculosis patients throughout anti-TB treatment journey","volume":"14","author":"Chen","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.jclinepi.2026.112443_bib26","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.2147\/IDR.S372351","article-title":"Development and validation of a nomogram for the prediction of unfavorable treatment outcome among multi-drug resistant tuberculosis patients in North West Ethiopia: an application of prediction modelling","volume":"15","author":"Anley","year":"2022","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jclinepi.2026.112443_bib27","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.2147\/IDR.S316268","article-title":"Khat chewing and clinical conditions determine the epidemiology of primary drug resistance tuberculosis in Amhara Region of Ethiopia: a multicenter Study","volume":"14","author":"Kassa","year":"2021","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jclinepi.2026.112443_bib28","doi-asserted-by":"crossref","first-page":"e0306076","DOI":"10.1371\/journal.pone.0306076","article-title":"Drug-resistant tuberculosis care and treatment outcomes over the last 15 years in Ethiopia: results from a mixed-method review of trends","volume":"19","author":"Tesema","year":"2024","journal-title":"PLOS ONE"},{"key":"10.1016\/j.jclinepi.2026.112443_bib29","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12874-024-02268-5","article-title":"An evaluation of sample size requirements for developing risk prediction models with binary outcomes","volume":"24","author":"Pavlou","year":"2024","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112443_bib30","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/2196-0739-1-4","article-title":"Multiple imputation using chained equations for missing data in TIMSS: a case study","volume":"1","author":"Bouhlila","year":"2013","journal-title":"Large-scale Assessments Educ"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112443_bib31","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s41512-019-0064-7","article-title":"A simple, step-by-step guide to interpreting decision curve analysis","volume":"3","author":"Vickers","year":"2019","journal-title":"Diagn prognostic Res"},{"key":"10.1016\/j.jclinepi.2026.112443_bib32","doi-asserted-by":"crossref","first-page":"42","DOI":"10.7326\/M20-0193","article-title":"Transparent reporting of multivariable prediction models in journal and conference abstracts: TRIPOD for abstracts","volume":"173","author":"Heus","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jclinepi.2026.112443_bib33","article-title":"The persistent threat of tuberculosis \u2212 why ending TB remains elusive?","volume":"38","author":"Suvvari","year":"2025","journal-title":"J Clin Tubercul Other Mycobacterial Dis"},{"key":"10.1016\/j.jclinepi.2026.112443_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198075","article-title":"A combination of quantitative and qualitative methods in investigating risk factors for lost to follow-up for tuberculosis treatment in Japan\u2013Are physicians and nurses at a particular risk?","volume":"13","author":"Kawatsu","year":"2018","journal-title":"PloS one"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112443_bib35","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1186\/s12890-024-03350-w","article-title":"Multidrug-resistant tuberculosis treatment outcomes and associated factors at Yirgalem General Hospital, Sidama Region, South Ethiopia: a retrospective cohort study","volume":"24","author":"Kebede","year":"2024","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jclinepi.2026.112443_bib36","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1186\/s12889-022-13390-8","article-title":"Predictors of loss to follow-up among adult tuberculosis patients in Southern Ethiopia: a retrospective follow-up study","volume":"22","author":"Watumo","year":"2022","journal-title":"BMC Public Health"},{"issue":"8","key":"10.1016\/j.jclinepi.2026.112443_bib37","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-040862","article-title":"National treatment outcome and predictors of death and treatment failure in multidrug-resistant tuberculosis in Ethiopia: a 10-year retrospective cohort study","volume":"11","author":"Tola","year":"2021","journal-title":"BMJ Open"},{"issue":"9","key":"10.1016\/j.jclinepi.2026.112443_bib38","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S2213-2600(18)30235-2","article-title":"Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis: a retrospective cohort study","volume":"6","author":"Schnippel","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"8","key":"10.1016\/j.jclinepi.2026.112443_bib39","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.5588\/ijtld.12.0240","article-title":"A qualitative assessment of challenges to tuberculosis management and prevention in Northern Ethiopia","volume":"17","author":"Cowan","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"issue":"8","key":"10.1016\/j.jclinepi.2026.112443_bib40","doi-asserted-by":"crossref","first-page":"584","DOI":"10.2471\/BLT.17.193375","article-title":"Decentralized care for multidrug-resistant tuberculosis: a systematic review and meta-analysis","volume":"95","author":"Ho","year":"2017","journal-title":"Bull World Health Organ"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112443_bib41","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1186\/s12879-025-11503-3","article-title":"The impact of digital adherence technologies on treatment outcomes, adherence, and patient-reported outcomes in tuberculosis: a systematic review and meta-analysis","volume":"25","author":"Mohamed","year":"2025","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.jclinepi.2026.112443_bib42","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5588\/pha.21.0083","article-title":"Causes of loss to follow-up from drug-resistant TB treatment in Khayelitsha, South Africa","volume":"12","author":"Memani","year":"2022","journal-title":"Public Health Action"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112443_bib43","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1186\/s12879-025-10802-z","article-title":"Risk factors for poor outcomes in patients with drug-resistant tuberculosis: a 6-year multicenter prospective study in Zhejiang, China","volume":"25","author":"Feng","year":"2025","journal-title":"BMC Infect Dis"},{"issue":"4","key":"10.1016\/j.jclinepi.2026.112443_bib44","first-page":"430","article-title":"The profile of multidrug tuberculosis regimen and treatment outcomes in pulmonary MDR-TB patients at the tertiary referral Hospital Dr. Soetomo, East Java, Indonesia: a seven-year retrospective Study on bedaquiline","volume":"55","author":"Setyawan","year":"2023","journal-title":"Acta Med Indones"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112443_bib45","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00030-2019","article-title":"Predictors of loss to follow-up of tuberculosis cases under the DOTS programme in Namibia","volume":"6","author":"Kibuule","year":"2020","journal-title":"ERJ Open Res"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112443_bib46","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13031-024-00583-8","article-title":"War related disruption of clinical tuberculosis services in Tigray, Ethiopia during the recent regional conflict: a mixed sequential method study","volume":"18","author":"Gebrehiwot","year":"2024","journal-title":"Conflict and Health"},{"key":"10.1016\/j.jclinepi.2026.112443_bib47","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1186\/s12889-024-18815-0","article-title":"Machine learning algorithms using national registry data to predict loss to follow-up during tuberculosis treatment","volume":"24","author":"Rodrigues","year":"2024","journal-title":"BMC Public Health"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112443_bib48","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40249-023-01107-x","article-title":"Global prevalence of drug-resistant tuberculosis: a systematic review and meta-analysis","volume":"12","author":"Salari","year":"2023","journal-title":"Infect Dis Poverty"}],"container-title":["Journal of Clinical Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435626003197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435626003197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:06:36Z","timestamp":1793851596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0895435626003197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":48,"alternative-id":["S0895435626003197"],"URL":"https:\/\/doi.org\/10.1016\/j.jclinepi.2026.112443","relation":{},"ISSN":["0895-4356"],"issn-type":[{"value":"0895-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and internal validation of a clinical risk score for lost to follow-up among drug-resistant tuberculosis patients in a high-burden setting, Ethiopia, 2025: a multicenter retrospective follow-up study","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jclinepi.2026.112443","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112443"}}